Viewing Study NCT05213104

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:17 PM
Ignite Modification Date: 2025-12-28 @ 1:00 PM
Study NCT ID: NCT05213104
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-04-05
First Post: 2021-12-20
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Assessment of Flecainide to Lower the Patent Foramen Ovale Closure Risk of Atrial Arrhythmia or Tachycardia
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Patent Foramen Ovale View
None Atrial Arrhythmia View
None Cryptogenic Stroke View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cryptongenic stroke View
None Percutaneous Patent Foramen Ovale closure View
None randomized controlled trial View
None Patent Foramen Ovale View
None Atrial arrhythmia View
None Atrial Fibrillation View
None flecainide View